CALADRIUS BIOSCIENCES, INC.

Profile

Company Names

CALADRIUS BIOSCIENCES, INC.
NEOSTEM, INC.

Addresses

110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ 07920

106 ALLEN ROAD, FOURTH FLOOR, BASKING RIDGE, NJ 07920

420 LEXINGTON AVENUE, SUITE 350, NEW YORK, NY 10170

420 LEXINGTON AVENUE, SUITE 450, NEW YORK, NY 10170

Phone Numbers

908-842-0100
212-584-4180
212-584-4171

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$87,385,933.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2021-01-25 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
7
2020-07-15 
$1,999,994.00 
$1,999,994.00 
$0.00 
 
6
2020-05-28 
$2,150,002.00 
$2,150,002.00 
$0.00 
 
5
2020-04-27 
$2,432,437.00 
$2,432,437.00 
$0.00 
 
4
2016-09-14 
$12,600,000.00 
$21,000,000.00 
$8,400,000.00 
Equity 
3
2016-03-10 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
2
2014-05-08 
$38,000,000.00 
$38,000,000.00 
$0.00 
Equity 
1
2009-06-22 
$4,203,500.00 
$4,203,500.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
BERMAN 
DIRECTOR
DREW 
 
BERNSTEIN 
DIRECTOR
ROBERT 
 
DICKEY IV 
EXECUTIVE OFFICER
MARTYN 
D. 
GREENACRE 
DIRECTOR
STEVEN 
M. 
KLOSK 
DIRECTOR
DOUGLAS 
 
LOSORDO 
EXECUTIVE OFFICER
LARRY 
MAY 
EXECUTIVE OFFICER
DAVID 
 
MAZZO 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
J. 
MAZZO 
EXECUTIVE OFFICER, DIRECTOR
STEVEN 
MYERS 
DIRECTOR
STEVEN 
S. 
MYERS 
DIRECTOR
ANDREW 
L. 
PECORA 
DIRECTOR, EXECUTIVE OFFICER
STEPHEN 
W. 
POTTER 
EXECUTIVE OFFICER
ROBERT 
 
PRETI 
EXECUTIVE OFFICER
ROBERT 
A. 
PRETI 
EXECUTIVE OFFICER, DIRECTOR
CYNTHIA 
S. 
SCHWALM 
DIRECTOR
ROBIN 
SMITH 
EXECUTIVE OFFICER, DIRECTOR
ROBIN 
L. 
SMITH 
EXECUTIVE OFFICER, DIRECTOR
JOSEPH 
 
TALAMO 
EXECUTIVE OFFICER
PETER 
 
TRABER 
DIRECTOR
PETER 
G. 
TRABER 
DIRECTOR
CATHERINE 
 
VACZY 
EXECUTIVE OFFICER
CATHERINE 
VACZY 
EXECUTIVE OFFICER
ERIC 
H.C. 
WEI 
DIRECTOR
MARK 
 
WEINREB 
EXECUTIVE OFFICER
ANNE 
 
WHITAKER 
DIRECTOR
JOSEPH 
ZUCKERMAN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
SERVICES-MISC HEALTH + ALLIED SERVICES, NEC [8090] 
DECLINE TO DISCLOSE 
Equity 
2021-01-25 
D
BIOTECHNOLOGY 
SERVICES-MISC HEALTH + ALLIED SERVICES, NEC [8090] 
DECLINE TO DISCLOSE 
 
2020-07-15 
D
BIOTECHNOLOGY 
SERVICES-MISC HEALTH + ALLIED SERVICES, NEC [8090] 
DECLINE TO DISCLOSE 
 
2020-05-28 
D
BIOTECHNOLOGY 
SERVICES-MISC HEALTH + ALLIED SERVICES, NEC [8090] 
DECLINE TO DISCLOSE 
 
2020-04-27 
D
BIOTECHNOLOGY 
SERVICES-MISC HEALTH + ALLIED SERVICES, NEC [8090] 
$5,000,001 - $25,000,000 
Equity 
2016-09-14 
D
BIOTECHNOLOGY 
SERVICES-MISC HEALTH + ALLIED SERVICES, NEC [8090] 
$5,000,001 - $25,000,000 
Equity 
2016-03-10 
D
BIOTECHNOLOGY 
SERVICES-MISC HEALTH + ALLIED SERVICES, NEC [8090] 
DECLINE TO DISCLOSE 
Equity 
2014-05-08 
D
BIOTECHNOLOGY 
SERVICES-MISC HEALTH + ALLIED SERVICES, NEC [8090] 
DECLINE TO DISCLOSE 
Equity 
2009-06-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC3
375
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
PIPER JAFFRAY + CO.
665
GARDEN STATE SECURITIES, INC.
GARDEN STATE SECURITIES, INC.